Caifeng Xie

Dr. Caifeng Xie


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
JJJiangbo Jin
Jiangbo Jin
ZZZiyu Zhang
Ziyu Zhang
SZSong Zhang
Song Zhang
XCXinyu Chen
Xinyu Chen
ZCZhen Chen
Zhen Chen
CXCaifeng Xie
Caifeng Xie

23 October 2012 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
LMLiang Ma
Liang Ma
CXCaifeng Xie
Caifeng Xie
YRYan Ran
Yan Ran
XLXiao-Lin Liang
Xiao-Lin Liang
LHLi Huang
Li Huang
LCLijuan Chen
Lijuan Chen

25 April 2019 in Cell Cycle
Verified
Journal Article
Closed access
YWYanan Wang
Yanan Wang
THTianyu Han
Tianyu Han
MGMingxi Gan
Mingxi Gan
MGMeng Guo
Meng Guo
CXCaifeng Xie
Caifeng Xie
JWJian-Bin Wang
Jian-Bin Wang
The anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase, is responsible for the transition from metaphase to anaphase and the exit from mitosis. The anaphase promoting complex subunit 10 (APC10), a subunit of the APC/C, executes a vital function in substrate recognition. However, no research has reported the connection between APC10 and cancer until now. In this study, we uncovered a novel, unprecedented role of APC10 in tumor progression, which is independent of APC/C. First, aberrant increase of APC10 expression was validated in non-small cell lung cancer (NSCLC) cells and tissues, and the absence of APC10 repressed cell proliferation and migration. Of great interest, we found that APC10 inhibition induced cell cycle arrest at the G0/G1 phase and reduced the expression of the APC/C substrate, Cyclin B1; this finding is different from the conventional concept of the accumulation of Cyclin B1 and cell cycle arrest in metaphase. Further, APC10 was found to interact with glutaminase C (GAC), and the inhibition of APC10 weakened glutamine metabolism and induced excessive autophagy. Taken together, these findings identify a novel function of APC10 in the regulation of NSCLC tumorigenesis and point to the possibility of APC10 as a new target for cancer therapy.

16 September 2014 in Molecules
Verified
Journal Article
Open access
PDF file
LMLiang Ma
Liang Ma
LHLi Huang
Li Huang
HPHeying Pei
Heying Pei
ZLZhuowei Liu
Zhuowei Liu
CXCaifeng Xie
Caifeng Xie
LCLijuan Chen
Lijuan Chen
Mai Tong Fang (MTF), a Chinese herbal combination, has been used for the treatment of diabetic nephropathy in traditional medical clinics in China. However, the anti-adipogenic and anti-hyperglycemic effects of MTF have not been fully elucidated, so this study explored these pharmacological activities in 3T3-L1 adipocytes and ob/ob mice, respectively, of the water fraction of milkvetch root, salviae miltiorrhizae and mulberry as key components of MTF. MTF was found to inhibit adipogenesis and triglyceride accumulation in 3T3-L1 adipocytes. Oral administration of MTF in ob/ob mice for 8 weeks, exhibited positive controls on blood glucose and body weight, and further improved glucose tolerance according to an oral glucose tolerance test. Importantly, MTF extract alleviated fat deposition and ballooning degeneration in liver tissue and blocked the increase of adipocyte size in adipose tissue from treated ob/ob mice. These results indicated that the extract of key components in the traditional Chinese prescription MTF continue a potent anti-adipogenic and glucose-lowering agent.

27 September 2018 in RSC Advances
Verified
Journal Article
Open access
PDF file
JYJia Yu
Jia Yu
LLLili Liu
Lili Liu
HZHuiming Zhang
Huiming Zhang
YWYating Wu
Yating Wu
HPHeying Pei
Heying Pei
CXCaifeng Xie
Caifeng Xie
Acute liver failure is a severe clinical syndrome accompanied with excessive inflammatory response. Our previous study demonstrated that SKLB023, a novel thiazolidinedione derivative, showed potent anti-inflammatory activity in rheumatoid arthritis. The purpose of the present study is to evaluate the protective effect of SKLB023 on lipopolysaccharide (LPS)/D-GalN-induced liver failure and to explore the underlying molecular mechanisms. Our results showed that SKLB023 significantly improved mortality and liver injury as indicated by reduced serum levels of aminotransferases and alleviated pathological damage. Additionally, SKLB023 decreased the percentage of activated T cells and macrophages as well as the serum levels of cytokines in vivo. Furthermore, SKLB023 decreased levels of TNF-α and IL-6 secreted from liver macrophages (Kupffer cells) stimulated by LPS in vitro. Our results indicated that the protective effects of SKLB023 were associated with its significant impact on the inflammatory cytokines, which were produced by both T cells and macrophages.

4 August 2022 in Prostaglandins & Other Lipid Mediators
Verified
Journal Article
Closed access
SCShiyin Chen
Shiyin Chen
ZXZhen Xiong
Zhen Xiong
CMCheng MA
Cheng MA
BZBei Zhang
Bei Zhang
CXCaifeng Xie
Caifeng Xie